Optimal Length of Antidepressant Trials in Late-Life Depression

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Psychopharmacology

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.jcp.0000170683.25802.12PMID 16027559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment strategies in patients with major depression not responding to first-line sertraline treatment

  2002cited by this paper
• Citalopram treatment of fluoxetine nonresponders.

  2001cited by this paper
• A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.

  2000cited by this paper
• Timing of onset of antidepressant response with fluoxetine treatment.

  2000cited by this paper
• Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

  2000cited by this paper
• Diagnosis and treatment of depression in late life.

  1998cited by this paper
• Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.

  1997cited by this paper
• Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients.

  1996cited by this paper
• The effect of sequential antidepressant treatment on geriatric depression.

  1996cited by this paper
• Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

  1994cited by this paper
• Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.

  1989influential reference

• Moderators of treatment response in late-life depression.

  2026cites this paper
• KETO-MOOD: Ketogenic Diet for Microbiome Optimization and Overcoming Depression – A Protocol for a Randomized Controlled Trial

  2024cites this paper
• A New Solution to an Age-old Problem: A Review of Ketamine and Esketamine for Treatment-resistant Depression in Late Life

  2023cites this paper
• Pharmacotherapy for late-life depression

  2022cites this paper
• Mood Disorders: Predictors of tDCS Response

  2021cites this paper
• A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints.

  2020cites this paper
• Evidence based Psychiatric Care

  2020cites this paper
• Psychobiological factors of resilience and depression in late life

  2019cites this paper
• Resilience predicts remission in antidepressant treatment of geriatric depression

  2018cites this paper
• The Black Book of Psychotropic Dosing and Monitoring.

  2018cites this paper
• Quantitative Electroencephalography for Objective and Differential Diagnosis of Depression: A Comprehensive Review.

  2016cites this paper
• Clinical trials in late‐life mood disorders

  2016cites this paper
• Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.

  2015cites this paper
• Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.

  2015cites this paper
• Unmet needs and research challenges for late-life mood disorders

  2014cites this paper
• The placebo effect in psychiatry: problem or solution?

  2013cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

  2013cites this paper
• Depression in later life: an overview with treatment recommendations.

  2012cites this paper
• Geriatric mental health disaster and emergency preparedness

  2010cites this paper
• Recognition and Treatment of Late-LifeDepression

  2009cites this paper
• Early response as predictor of final remission in elderly depressed patients

  2009cites this paper
• Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.

  2009cites this paper
• Neuromodulating mice and men: Are there functional species differences in neurotransmitter concentration?

  2009cites this paper
• Pathological Laughing and Crying

  2008cites this paper
• Pharmacotherapy of Late-Life Depression: Evidence-Based Recommendations

  2008cites this paper
• Biologische behandlung unipolarer depressiver störungen in der allgemeinärztlichen versorgung: Leitlinien der World Federation of Societies of Biological Psychiatry (WFSBP)

  2008cites this paper
• Mood Disorders in Later Life

  2008cites this paper
• Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder

  2008cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

  2007cites this paper
• Limits of evidence-based medicine in older adults

  2007cites this paper
• Antidepressant tapering: avoiding adverse consequences of gradual dose reduction.

  2007cites this paper
• Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.

  2007cites this paper
• Achieving Adequate Outcomes in Geriatric Depression: Standardized Criteria for Remission

  2005cites this paper
• The Efficacy of Antidepressants in the Treatment of Late-Life Depression

  2005cites this paper